Literature DB >> 2211670

Feedback regulation of phospholipase C-beta by protein kinase C.

S H Ryu1, U H Kim, M I Wahl, A B Brown, G Carpenter, K P Huang, S G Rhee.   

Abstract

Treatment of a variety of cells and tissues with 12-O-tetradecanoylphorbol-13-acetate (TPA), an activator of protein kinase C (PKC) results in the inhibition of receptor-coupled inositol phospholipid-specific phospholipase C (PLC) activity. To determine whether or not the targets of TPA-activated PKC include one or more isozymes of PLC, studies were carried out with PC12, C6Bu1, and NIH 3T3 cells, which contain at least three PLC isozymes, PLC-beta, PLC-gamma, and PLC-delta. Treatment of the cells with TPA stimulated the phosphorylation of serine residues in PLC-beta, but the phosphorylation state of PLC-gamma and PLC-delta was not changed significantly. Phosphorylation of bovine brain PLC-beta by PKC in vitro resulted in a stoichiometric incorporation of phosphate at serine 887, without any concomitant effect on PLC-beta activity. We propose, therefore, that rather than having a direct effect on enzyme activity, the phosphorylation of PLC-beta by PKC may alter its interaction with a putative guanine nucleotide-binding regulatory protein and thereby prevent its activation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2211670

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  A lobster phospholipase C-beta that associates with G-proteins in response to odorants.

Authors:  F Xu; T S McClintock
Journal:  J Neurosci       Date:  1999-06-15       Impact factor: 6.167

Review 2.  The recombinant 5-HT1A receptor: G protein coupling and signalling pathways.

Authors:  J R Raymond; Y V Mukhin; T W Gettys; M N Garnovskaya
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

Review 3.  Inositol-lipid-specific phospholipase C isoenzymes and their differential regulation by receptors.

Authors:  S Cockcroft; G M Thomas
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

4.  Reciprocal modulation of phospholipase Cbeta isoforms: adaptation to chronic morphine.

Authors:  Sumita Chakrabarti; Nai-Jiang Liu; Alan R Gintzler
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-03       Impact factor: 11.205

5.  Chronic exposure to high glucose impairs bradykinin-stimulated nitric oxide production by interfering with the phospholipase-C-implicated signalling pathway in endothelial cells: evidence for the involvement of protein kinase C.

Authors:  Y Tang; G D Li
Journal:  Diabetologia       Date:  2004-12-15       Impact factor: 10.122

6.  Metabotropic glutamate receptors regulate hippocampal CA1 pyramidal neuron excitability via Ca²⁺ wave-dependent activation of SK and TRPC channels.

Authors:  Lynda El-Hassar; Anna M Hagenston; Lisa Bertetto D'Angelo; Mark F Yeckel
Journal:  J Physiol       Date:  2011-05-16       Impact factor: 5.182

7.  Xenopus Gq alpha subunit activates the phosphatidylinositol pathway in Xenopus oocytes but does not consistently induce oocyte maturation.

Authors:  K L Guttridge; L D Smith; R Miledi
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

8.  Regulation of Gβγi-dependent PLC-β3 activity in smooth muscle: inhibitory phosphorylation of PLC-β3 by PKA and PKG and stimulatory phosphorylation of Gαi-GTPase-activating protein RGS2 by PKG.

Authors:  Ancy D Nalli; Divya P Kumar; Othman Al-Shboul; Sunila Mahavadi; John F Kuemmerle; John R Grider; Karnam S Murthy
Journal:  Cell Biochem Biophys       Date:  2014-11       Impact factor: 2.194

9.  1,25-Dihydroxyvitamin D3 upregulates the phosphatidylinositol signaling pathway in human keratinocytes by increasing phospholipase C levels.

Authors:  S Pillai; D D Bikle; M J Su; A Ratnam; J Abe
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

10.  Regulation of Clostridium perfringens alpha-toxin-activated phospholipase C in rabbit erythrocyte membranes.

Authors:  J Sakurai; S Ochi; H Tanaka
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.